genomewide characterization of host-pathogen interactions by ...
genomewide characterization of host-pathogen interactions by ...
genomewide characterization of host-pathogen interactions by ...
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
mean normalized intensity<br />
mean normalized intensity<br />
Maren Depke<br />
Results<br />
Pathogen Gene Expression Pr<strong>of</strong>iling<br />
A<br />
B<br />
10.0 10,0<br />
fold change in comparison to<br />
baseline 1 h serum/CO 2 control<br />
S. aureus<br />
RN1HG<br />
sample<br />
conditions<br />
and time<br />
points<br />
dltA dltB dltC dltD lytM ssaA<br />
exponential growth phase 1.0 -1.0 -1.0 -1.2 2.6 1.2<br />
2.5 h internalized -2.5 -2.2 -1.6 -2.2 2.4 3.0<br />
6.5 h internalized -1.5 -1.3 -1.2 -1.3 2.1 2.9<br />
2.5 h serum/CO 2 control 1.0 -1.0 1.1 -1.1 1.4 1.3<br />
6.5 h serum/CO 2 control -2.5 -2.4 -2.5 -2.4 1.5 -1.9<br />
2.5 h anaerobic incubation -2.0 -2.2 -1.9 -2.7 -3.3 -2.5<br />
1.0 1,0<br />
dltA<br />
dltB<br />
dltC<br />
dltD<br />
lytM<br />
ssaA<br />
Fig. R.5.18: Cell wall associated gene expression.<br />
A. Overview on fold change values relative to the baseline sample “1 h serum/CO 2 control” and on significance in statistical group<br />
comparisons. Differentially expressed genes are marked <strong>by</strong> gray filling for the corresponding sample condition/time point.<br />
Genes which were significant in statistical testing (p* < 0.05) but did not pass the absolute fold change cut<strong>of</strong>f 2 are indicated in bold<br />
without filling. The sample “6.5 h serum/CO 2 control” could not be included in statistical testing because <strong>of</strong> small group size (n = 2).<br />
B. Overview on mean normalized gene expression intensity. After the global normalization <strong>by</strong> inter-chip scaling and detrending, each<br />
individual gene has been normalized to the expression level <strong>of</strong> the baseline sample “1 h serum/CO 2 control”. Although not being<br />
continuous data, values were depicted as line graphs instead <strong>of</strong> bar charts for better facility <strong>of</strong> inspection.<br />
(exp. − exponential growth phase; 1 h co. – 1 h serum/CO 2 control; 2.5 h int. − 2.5 h internalization; 6.5 h int. − 6.5 h internalization;<br />
2.5 h co. − 2.5 h serum/CO 2 control; 6.5 h co. − 6.5 h serum/CO 2 control; 2.5 h anae. − 2.5 h anaerobic incubation)<br />
0.1 0,1<br />
exp.<br />
1 h<br />
co.<br />
2.5 h<br />
int.<br />
6.5 h<br />
int.<br />
2.5 h<br />
co.<br />
6.5 h<br />
co.<br />
2.5 h<br />
anae.<br />
S. aureus RN1HG sample conditions and time points<br />
Bi<strong>of</strong>ilm formation is another option for S. aureus to protect the bacterial cells from the<br />
immune system and antimicrobials. Here, bacterial cells are surrounded <strong>by</strong> a polysaccharide<br />
matrix, composed <strong>of</strong> poly-N-acetylglucosamine (PNAG). The ica operon encodes the proteins<br />
necessary for PNAG biosynthesis. Of this operon, the icaB gene was repressed in internalized and<br />
control samples <strong>of</strong> the infection experiment. The icaC and icaD genes behaved similarly, but were<br />
significantly repressed only at the 2.5 h time point <strong>of</strong> internalization. The fourth gene <strong>of</strong> the<br />
operon, icaA, and the separately encoded repressor gene, icaR, were not differentially expressed<br />
(Fig. R.5.19 A, B). Furthermore, it was obvious that the expression intensity <strong>of</strong> icaADBC was low.<br />
A<br />
B<br />
10,0 10.0<br />
fold change in comparison to<br />
baseline 1 h serum/CO 2 control<br />
S. aureus<br />
RN1HG<br />
sample<br />
conditions<br />
and time<br />
points<br />
icaR icaA icaD icaB icaC<br />
exponential growth phase -1.0 2.0 1.6 1.7 1.6<br />
2.5 h internalized -1.2 1.4 -2.2 -3.7 -2.8<br />
6.5 h internalized -1.0 1.0 -1.3 -2.2 -1.5<br />
2.5 h serum/CO 2 control -1.4 1.3 1.1 -2.2 1.1<br />
6.5 h serum/CO 2 control -1.2 1.2 1.5 -1.9 -1.4<br />
2.5 h anaerobic incubation -1.3 1.1 -1.6 -2.4 -1.4<br />
Fig. R.5.19: Bi<strong>of</strong>ilm associated gene expression.<br />
A. Overview on fold change values relative to the baseline sample “1 h serum/CO 2 control” and on significance in statistical group<br />
comparisons. Differentially expressed genes are marked <strong>by</strong> gray filling for the corresponding sample condition/time point.<br />
Genes which were significant in statistical testing (p* < 0.05) but did not pass the absolute fold change cut<strong>of</strong>f 2 are indicated in bold<br />
without filling. The sample “6.5 h serum/CO 2 control” could not be included in statistical testing because <strong>of</strong> small group size (n = 2).<br />
B. Overview on mean normalized gene expression intensity. After the global normalization <strong>by</strong> inter-chip scaling and detrending, each<br />
individual gene has been normalized to the expression level <strong>of</strong> the baseline sample “1 h serum/CO 2 control”. Although not being<br />
continuous data, values were depicted as line graphs instead <strong>of</strong> bar charts for better facility <strong>of</strong> inspection.<br />
(exp. − exponential growth phase; 1 h co. – 1 h serum/CO 2 control; 2.5 h int. − 2.5 h internalization; 6.5 h int. − 6.5 h internalization;<br />
2.5 h co. − 2.5 h serum/CO 2 control; 6.5 h co. − 6.5 h serum/CO 2 control; 2.5 h anae. − 2.5 h anaerobic incubation)<br />
1,0 1.0<br />
0,1 0.1<br />
exp.<br />
1 h<br />
co.<br />
2.5 h<br />
int.<br />
6.5 h<br />
int.<br />
2.5 h<br />
co.<br />
6.5 h<br />
co.<br />
2.5 h<br />
anae.<br />
S. aureus RN1HG sample conditions and time points<br />
icaR<br />
icaA<br />
icaD<br />
icaB<br />
icaC<br />
153